8th T Cell Engager Therapeutics Summit 2026

23rd June 2026 - 25th June 2026

Trailblazing Immunotherapies to Transform the Oncology & Autoimmune Landscapes, the 8th T‑Cell Engager Therapeutics Summit 2026 is the longest‑running, industry‑led meeting dedicated exclusively to T‑cell engager innovation.

Taking place June 23–25, 2026 in San Diego, the summit brings together a highly focused audience of senior biotech and pharma leaders advancing next‑generation TCE programs. With 120+ attendees and 28+ expert speakers, this case study driven forum delivers practical insights across discovery, engineering, translational and clinical development.

The summit offers targeted networking, strategic collaboration opportunities, and critical learnings to accelerate safer, more effective T‑cell engagers into the clinic.

3rd Global Cell and Gene Therapy Summit 2026

06th July 2026 - 08th July 2026

The 3rd Global Cell and Gene Therapy Summit 2026 is a premier event bringing together experts, researchers, and industry leaders to explore the latest advancements in cell and gene therapy. The summit will feature thought-provoking sessions, case studies, and networking opportunities to foster innovation, collaboration, and strategic partnerships in the rapidly evolving landscape of biopharmaceutical science.

2nd Operationalize: Expanded Access Programs Summit West 2026

14th July 2026 - 16th July 2026

The 2nd Operationalize: Expanded Access Programs Summit West unites West Coast biotech and pharma leaders to advance patient access through robust, scalable Expanded Access and Post‑Trial Access Programs.

Taking place July 14–16, 2026 in San Francisco, the summit brings together senior experts across Medical Affairs, Regulatory, Clinical Operations, and Clinical Supply to share practical strategies for navigating evolving U.S. and global regulations, optimizing ethical real‑world data collection, and managing long‑duration and rare‑disease programs.

Designed as a peer‑led, non‑competitive forum, this meeting delivers actionable insights to help teams build sustainable, compliant, and patient‑centered access pathways.

5th Process Development & Automation for Cell Therapies Summit 2026

14th July 2026 - 16th July 2026

The 5th Process Development & Automation for Cell Therapies Summit is the only industry‑led meeting in 2026 dedicated exclusively to advancing robust, scalable cell therapy processes.

Built by biopharma, for biopharma, this summit brings together process development, MSAT, analytical, and automation leaders to tackle the real‑world challenges impacting comparability, CMC readiness, and manufacturing success.

Join senior experts from leading biopharma companies to explore applied automation, platform selection, digital tools, and data‑driven strategies that enable confident scale‑up and regulatory alignment.

If your goal is to future‑proof cell therapy development, this is the meeting you need to attend.

6th mRNA Based Therapeutics Summit 2026

20th July 2026 - 22nd July 2026

From major industry‑shaping acquisitions – including Eli Lilly & Orna, BMS & Orbital, AbbVie & Capstan, and BioNTech & CureVac – the mRNA landscape is accelerating rapidly, with assets in in vivo CAR‑T, gene editing, and cancer immunotherapies moving closer to clinical validation and future commercial reality.

Against this backdrop of scientific momentum, the 6th mRNA‑Based Therapeutics Summit returns to Boston this summer as the world’s flagship gathering for the mRNA community. Uniting 350+ global leaders across pharma giants, pioneering biotechs, and regulatory agencies – including Moderna, Pfizer, AstraZeneca, Sanofi, ParcelBio, CaVos Therapeutics, Kernal Biologics, the US FDA, the MHRA and the EMA – the summit showcases exclusive breakthroughs, regulatory perspectives, and cross‑industry collaboration shaping the future of mRNA innovation.

Featuring a revitalized three‑track agenda spanning Discovery, Pre‑Clinical & Clinical Development, and Manufacturing & CMC, plus two brand‑new focus days on AI‑Driven mRNA Design and Next‑Gen Delivery Technologies, the summit stands as the leading platform for scientific exchange, partnership building, and pipeline acceleration.

Join the global community advancing mRNA science and power the next wave of therapies and tools set to transform human health.

5th Liquid Biopsy for Precision Oncology Summit East Coast 2026

20th July 2026 - 22nd July 2026

Join senior biopharma and diagnostic leaders at the forefront of liquid biopsy innovation at the 5th Liquid Biopsy for Precision Oncology Summit East Coast in the united goal of redefining how ctDNA, MRD and multi-omic profiling are transforming oncology drug development.

You can expect to participate in regulatory-ready discussions on MRD as an endpoint, hear cutting-edge data on molecular response and durability, and gain practical insights into companion diagnostics, dose optimization and scalable deployment.

Through focused presentations, panels, interactive roundtables and high-value networking, acquire the evidence, partnerships and strategic clarity needed to move from exploratory signal to confident, decision-grade precision oncology.

Autoimmune Neuromuscular & Nerve Disorders Drug Development Summit 2026

21st July 2026 - 23rd July 2026

The Autoimmune Neuromuscular & Nerve Disorders Drug Development Summit is the first industry-led forum dedicated to transforming the MG, CIDP, GBS and MMN treatment landscapes, bringing together biopharma leaders to tackle the mechanistic and translational challenges shaping this rapidly evolving space.

This meeting is uniquely positioned to address these challenges. Unlike pathway-specific or clinician-led events, it is indication-focused, mechanism-driven and tailored exclusively to drug developers, enabling deeper discussion on pathophysiology, differentiation and translational strategy.

9th International Neoantigen Summit 2026

21st July 2026 - 23rd July 2026

As the only conference focused on neoantigens, the 9th International Neoantigen Summit returns to Amsterdam as the most timely and essential gathering for the field.

As your only chance this year to address the full translational journey – from antigen identification and validation through to biomarker strategy, clinical trial readouts and therapeutic efficacy – it’s not one to miss.

With 30% c-level attendees & 6 new speaking companies, including CellVax Therapeutics, Echo Immune, Epitopea and Khosen Bio, this convenes 70+ biopharma pioneers shaping the next generation of immunotherapies.

Every session is curated for relevance, and every interaction is designed to foster meaningful collaboration.

5th In Vivo Cell Engineering & Gene Editing Summit 2026

28th July 2026 - 30th July 2026

The 5th In Vivo Cell Engineering & Gene Editing Summit is the leading global meeting dedicated to advancing targeted in vivo delivery, next-generation editing technologies, and emerging clinical data.

Uniting pioneering biopharma, investors, and scientific leaders, the summit explores breakthroughs in extrahepatic delivery, enhanced specificity and durability, and first-in-human readouts that are defining the field’s rapid evolution.

With a dedicated focus on Asia’s accelerating clinical ecosystem and partnerships, attendees gain practical insights to advance programs toward scalable, safer, and more accessible in vivo therapies. Join the community shaping the future of cell and gene engineering.

4th ADC Linker & Conjugation Summit 2026

28th July 2026 - 30th July 2026

This July, the 4th ADC Linker & Conjugation Summit offers a highly technical, deeply curated environment built specifically for specialists working at the cutting edge of ADC chemistry.

Join 80+ discovery chemists, protein engineers, and translational leaders in Boston for three days of deep technical exploration into linker architecture, conjugation precision, and platform scalability.

Through hands-on workshops, technical debates, collaborative networking and 20+ expert-led case studies, this summit gives you the rare opportunity to shape the linker and conjugation strategies that will define the next decade of ADC development.

Event Dates: July 28-30, 2026

Event Location: Revere Hotel Boston Common, 200 Stuart St, Boston, MA 02116, United States

3rd Structure-Based Drug Design Summit Boston 2026

28th July 2026 - 30th July 2026

The 3rd Structure-Based Drug Design Summit Boston returns as the go-to industry-dedicated forum focused exclusively on the practical application of structural biology and AI across early drug discovery workflows.

Designed for structural biologists, medicinal chemists, computational scientists, and discovery leaders, it showcases how leading organizations apply cryo-EM, structural data, and predictive modelling to guide target selection, optimize compounds, and strengthen discovery decisions.

Through expert-led case studies, interactive discussions, and collaborative networking, attendees will gain practical insight into solving complex targets across modalities, from membrane proteins and GPCRs to induced-proximity therapeutics, biologics, and next-generation modalities, making this a must-attend meeting for industry professionals.

BioProcess International India 2026

13th August 2026 - 14th August 2026

BioProcess International India marks a pivotal expansion of the globally recognized BioProcess International Conference Series into one of the world’s fastest-growing biomanufacturing markets.

This landmark event will establish the definitive platform where India’s dynamic bioprocessing ecosystem connects with international expertise to accelerate the next phase of biomanufacturing excellence.

Building on decades of global expertise, we’re fostering partnerships with regional industry leaders to transform life-changing therapies from scientific possibility to patient reality.

5th Oligonucleotide Analytical Development & CMC Summit 2026

17th August 2026 - 19th August 2026

Taking place in Boston, August 17–19, 2026, the 5th Oligonucleotide Analytical Development & CMC Summit is the premier forum for advancing oligonucleotide therapeutics development.

Featuring leaders from Alnylam, Biogen, Ionis Pharmaceuticals, Amgen, and Avidity Biosciences, the event addresses key challenges in analytical complexity, impurity control, and CMC strategy.

Participants will explore cutting-edge analytical techniques, evolving regulatory expectations, and scalable approaches for ASOs, siRNA, and conjugates.

With opportunities to network with 90+ industry experts, attendees will gain practical insights to enhance product quality, comparability, and regulatory readiness and accelerate programs toward successful commercialization.

the 6th Rare & Genetic Kidney Disease Drug Development Summit 2026

18th August 2026 - 20th August 2026

The 6th Rare & Genetic Kidney Disease Drug Development Summit brings together leading experts from biopharma and academia to accelerate therapeutic innovation across rare and inherited renal disorders.

Taking place August 18–20, 2026 in Boston, this industry‑dedicated forum spans discovery through commercialization, highlighting advances in surrogate endpoint validation, targeted modalities, omics‑driven patient stratification, and patient‑centric clinical development.

With growing investment, multiple recent approvals, and heightened competition in IgAN, FSGS, PKD, Alport Syndrome, and C3G, the summit provides an essential platform to share emerging insights, overcome shared challenges, and shape the future of rare kidney drug development.

ISPE Singapore Conference & Exhibition 2026

19th August 2026 - 21st August 2026

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. The annual meeting highlights best practices and services – from manufacturing facility design to finished product.

This is your opportunity to gather the latest updates and knowledge from your industry colleagues and subject matter experts!

6th Annual Oligonucleotides for CNS Summit 2026

19th August 2026 - 21st August 2026

The 6th Annual Oligonucleotides for CNS Summit is a leading scientific conference dedicated to advancing oligonucleotide-based therapeutics for central nervous system (CNS) disorders.

Taking place on August 19–21, 2026 in Boston, MA, the event brings together 160+ experts across CNS biology, RNA science, oligonucleotide chemistry, and translational pharmacology.

Attendees explore cutting‑edge developments in siRNAs, ASOs, aptamers, and novel delivery technologies, with a strong focus on overcoming previously undruggable CNS targets.

Through three days of data‑driven presentations, workshops, and networking, the summit accelerates collaboration and innovation in next‑generation CNS‑targeted RNA therapies.

RNA Leaders APAC 2026

01st September 2026 - 02nd September 2026

RNA Leaders APAC is the go-to event for advancing RNA-based therapeutics and vaccines in the Asia-Pacific region. With a focus on the region’s growing biotech hubs and unique industry needs, this conference explores innovations in mRNA, siRNA, and antisense technologies.

Attendees will gain insights into overcoming delivery hurdles, navigating diverse regulatory environments, and scaling manufacturing for APAC markets.

Featuring expert-led sessions and tailored networking opportunities, RNA Leaders APAC connects global experts with local innovators to drive RNA advancements in this dynamic region.

Don’t miss out, register now and use the 15% discount code (MMBipPharma) to secure your spot.

BPI APAC 2026

31st August 2026 - 02nd September 2026

BioProcess International APAC is the premier bioprocessing conference bringing together industry leaders to explore cutting-edge advancements in biologics and novel modalities.

Master the transition to connected manufacturing across the full product lifecycle, redefining bioprocessing operations, efficiency and sustainability.

6th iPSC Drug Development Summit 2026

09th September 2026 - 10th September 2026

The 6th iPSC Drug Development Summit convenes senior biopharma leaders advancing induced pluripotent stem cell therapies from discovery through clinical scale-up.

The meeting delivers deep, technical discussion across preclinical translation, CMC strategy, GMP-ready manufacturing, and regulatory alignment, with data-driven case studies from companies actively progressing programs. Speaker organizations include BlueRock Therapeutics, Aspen Neuroscience, Century Therapeutics, Astellas Pharma, Oryon Cell Therapies, BroadOak Capital, and more.

Designed for decision-makers shaping development strategy, the summit provides practical insight into execution risks, platform choices, and scalability considerations. Structured networking enables peer-level exchange among developers tackling shared scientific and operational challenges across cell therapy.

Continue Reading To Find out more…

Oncology & Immunology Innovation Partnering & Licensing Summit 2026

09th September 2026 - 10th September 2026

For biotech across ADCs, TCEs, BsAbs, TPD, and in vivo CAR-T, competing to align earlier clinical proof-of-concept data with pharma expectations, the Oncology & Immunology Innovation Partnering & Licensing Summit is the gateway to multiple high-impact, in-person meetings – without the distractions of a more diverse setting.

Designed around pharma teams scouting best-or-first-in-class candidates to compare competitive assets and technologies against a scientifically relevant context, this is the best opportunity in your conference calendar to remain relevant with the right decision-makers.

Through a dedicated one-to-one partnering system, organized matchmaking, and total audience alignment, pharma can efficiently meet, provide feedback on, and compare licensing and co-development opportunities, whilst biotech business development can cut through the noise and competition to secure guaranteed meetings with key stakeholders.

Join us this September to refine your strategy, sharpen your positioning, and understand expectations for deal conversations.

16th American Drug Delivery & Formulation Summit 2026

14th September 2026 - 15th September 2026

The 16th American Drug Delivery & Formulation Summit brings together an outstanding faculty of industry-leading speakers for two days of high-level scientific and strategic insight. Now firmly established as a must-attend event, the summit continues to grow year on year, welcoming over 450 scientific and industry leaders from pharma, biotech, and drug delivery organizations in its most recent edition.

Attendees will engage with a comprehensive program addressing critical challenges, emerging technologies, and formulation strategies shaping the future of drug delivery. Extensive networking opportunities foster meaningful connections, collaboration, and business growth across the global drug delivery community.

11th CAR-TCR Summit 2026

15th September 2026 - 17th September 2026

The 11th CAR-TCR Summit is your must attend forum, bringing together the latest scientific innovation across therapeutic classes and indications to inform your business strategy and support long term commercial success.

Renowned for its caliber of networking and unparalleled depth of content, expect cutting-edge clinical data on ex vivo and in vivo advances, clinical trial strategies to support expanded patient access across indications, scalable and automated manufacturing processes to improve speed and costs, as well as commercial reflections to learn from those on the market.

9th Neuropsychiatric Drug Development Summit 2026

15th September 2026 - 17th September 2026

Despite recent Phase II and III setbacks, neuropsychiatric drug development is regaining momentum, driven by progress across neuroplastogens, muscarinics, psychedelics, and other emerging modalities, alongside increasing regulatory support and investment.

Learnings from recent failures are informing more resilient, biology‑first development strategies, with greater emphasis on patient stratification, biomarkers, and translational frameworks to address placebo effects, heterogeneity, and late‑stage attrition.

Bringing together 150+ senior leaders and 46+ speakers from leading pharma, biotech, and investment organisations, the 9th Neuropsychiatric Drug Development Summit serves as a key forum for advancing precision psychiatry and patient‑centred mental health innovation.

Measuring Patient Engagement Summit Europe 2026

15th September 2026 - 17th September 2026

The Measuring Patient Engagement Summit Europe is the leading forum uniting biopharma’s patient engagement leaders, advocates, and digital health experts to explore how meaningful engagement measurement drives improved outcomes.

Attendees will explore case studies and proven, practical strategies that enable organisations to understand, measure, and interpret engagement into defensible, KPIs that influence decision-making.

With interactive sessions and high-level networking, the conference provides a collaborative environment to share best practice and better embed patient engagement as a proven driver of innovation across the entire development cycle and patient journey.

Simply measuring activity is no longer enough – it’s measuring impact that truly moves the needle today.

World Patient Safety Congress Europe 2026

22nd September 2026 - 24th September 2026

The World Patient Safety Congress Europe (formerly known as World Drug Safety Congress Europe is the premier global marketplace for C-suite executives, R&D specialists, and data leaders to define the future of pharmacovigilance and patient safety.

Taking place from September 22–24, 2026, at the RAI Amsterdam, this event explores the intersection of drug safety strategy and technological disruption.

This premier event brings together over 1,800 leaders from pharma, biotech, and regulatory bodies to explore the future of pharmacovigilance.

The congress features over 250 speakers and 10 content tracks focusing on the role of AI, automation, and Real-World Evidence (RWE) in safety monitoring and risk management.

By bringing together international regulatory bodies, industry professionals, and patient representatives, the event aims to foster a collaborative culture of innovation that improves safety outcomes across pharmaceutical drugs, medical devices, and consumer products

5th Lipid Nanoparticles Development Summit Europe 2026

23rd September 2026 - 24th September 2026

The 5th Lipid Nanoparticles Development Summit Europe returns to Berlin, 23–24 September 2026, as the leading meeting for advancing LNP-enabled gene therapy delivery.

Bringing together experts from BioNTech, AstraZeneca, Johnson & Johnson, Sanofi and AbbVie, the summit covers end-to-end LNP development, from formulation through to analytics, CMC and scalable manufacturing.

Attendees will explore solutions to overcome liver tropism, enable extrahepatic delivery and engineer next-generation nanoparticle systems across mRNA, DNA and gene editing therapies.

With interactive discussions and real-world case studies, this event delivers actionable insights to accelerate safe, targeted and clinically viable delivery platforms.

8th Exosome-Based Therapeutics Summit 2026

22nd September 2026 - 24th September 2026

The 8th Exosome-Based Therapeutics Summit is the premier forum for advancing clinical and commercial success in exosome and extracellular vesicle therapies.

As the field progresses into later-stage trials, this meeting focuses on optimizing clinical strategies, scaling manufacturing, and strengthening analytical testing to meet evolving regulatory expectations.

Bringing together industry pioneers, the summit fosters alignment across CMC, development, and regulatory pathways to de-risk platform growth and maximize investment potential.

Join leaders in Boston to exchange insights, accelerate clinical progress, and drive the next generation of scalable, compliant exosome-based therapeutics toward approval and commercialization.

RNA Leaders USA 2026

23rd September 2026 - 25th September 2026

RNA Leaders USA is the premier event for advancing RNA-based therapeutics and vaccines in North America. Join leading scientists, biotech innovators, and pharmaceutical experts as they explore the latest breakthroughs in mRNA, siRNA, and antisense technologies.

This conference tackles key challenges in drug development, delivery systems, and large-scale manufacturing, offering actionable insights and opportunities for collaboration.

With thought-provoking panels and networking sessions, RNA Leaders USA is the ultimate platform for driving innovation in RNA medicine.

Register today and use the 15% discount code (MMBiopharma) to be part of the movement shaping the future of healthcare.

BioProcess International 2026

22nd September 2026 - 25th September 2026

BioProcess International is a premier global conference and exhibition series that brings together bioprocessing professionals, scientists, engineers, and industry decision-makers to advance biologics manufacturing.

The flagship event focuses on transforming bioprocessing breakthroughs into manufacturing reality, covering critical areas including cell line development, upstream and downstream processing, digital biomanufacturing, CMC strategy, and cell and gene therapy.

Engage with over 3,000+ global bioprocessing professionals, 250+ solution & technology providers and 250+ expert speakers in Boston, MA this September.

BioTechX USA 2026

29th September 2026 - 30th September 2026

BioTechX USAbridges the gap between pharma, academia, and clinicians to foster meaningful collaborations across diagnostics, precision medicine, digital transformation, data management, AI, and innovation.

Connect with industry leaders, visionaries, and solution providers to discover new partnerships, innovations, and opportunities shaping the future of healthcare and life sciences.

Get ready for discovery. Get ready for BioTechX USA.

7th Genome Editing Therapeutics Summit 2026

28th September 2026 - 30th September 2026

The 7th Genome Editing Therapeutics Summit returns to Boston this September as the only industry-focused meeting dedicated to applying breakthrough genome editing tools directly to the therapeutic setting.

Join R&D, preclinical, translational, regulatory, and c-suite leaders to answer one question: how do we maximize the application of genome editing therapies to patients who need them most?

Don’t miss out on insights from AbbVie, Bristol Myers Squibb, Intellia Therapeutics, Beam Therapeutics, Sanofi, and others on how genome editing can move from a promising therapy to an essential one for patients facing the most genetically complex diseases.

Event Dates: September 28-30, 2026

Event Location: Boston, MA

mRNA Process Development & CMC Summit 2026

29th September 2026 - 01st October 2026

The mRNA Process Development & CMC Summit returns for its 5th Anniversary!

As the field continues to evolve at pace, this milestone edition is your opportunity to connect, learn, and stay ahead of the curve with the leaders shaping the future of mRNA therapeutics, including senior decision-makers from GSK, Eli Lilly, Centivax, Circurna, Sanofi, BioNTech and more!

From scaling processes and strengthening analytical capabilities to navigating global expansion and clinical readiness, this is where the industry’s most pressing CMC challenges are tackled head-on.

Don’t miss your chance to be part of our biggest edition yet!

Cell & Gene Meeting on the Mesa 2026

05th October 2026 - 07th October 2026

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference, bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.

Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space.

LEAP HR: Life Sciences East 2026

05th October 2026 - 07th October 2026

LEAP HR: Life Sciences East is the definitive ROI-driven meeting for senior HR, Talent Acquisition, and Learning & Development leaders across the life sciences industry.

Designed to ensure you move beyond theory, this event delivers practical, ROI-backed strategies that truly deliver measurable people and business impact.

Join a community of 200+ life sciences people leaders tackling critical challenges from scaling talent pipelines to enabling high-performance cultures in a rapidly evolving and turbulent sector.

Through case studies, peer discussions, and active workshops, you will leave equipped with the solutions you need to improve workforce performance, accelerate innovation, and drive sustainable growth in your organisation.

BioTechX EU 2026

06th October 2026 - 08th October 2026

BioTechX connects every vertical across the entire biotech and pharmaceutical ecosystem – drug discovery, clinical trials, R&D, data science, tech pioneers, investors, and pharma leaders – with a focus on innovation, data integration, and accelerating drug development.

Leaders and visionaries from across the global life science value chain gather for an unparalleled opportunity to learn, innovate, partner, and do business. Be part of a converged marketplace where collaboration matters, and advancements in patient care are exponential.

Get ready for discovery. Get ready for BioTechX.

16th World Clinical Biomarkers & Companion Diagnostics Summit 2026

05th October 2026 - 08th October 2026

The 16th World Clinical Biomarkers & Companion Diagnostics Summit is the industry’s leading global forum dedicated to advancing precision medicine through biomarker and diagnostic innovation.

Returning to Boston, we will unite more than 850 senior leaders from biopharma, diagnostics, regulatory bodies, healthcare organizations, and testing laboratories.

Joining us will ensure you access the latest developments in biomarker discovery, companion diagnostics, liquid biopsy, multi-omics, digital pathology, AI-driven diagnostics, and regulatory strategies.

With expert-led presentations, real-world case studies, strategic partnership discussions, and extensive networking opportunities, the forum provides a comprehensive platform to accelerate drug-diagnostic development and improve global patient access to personalized therapies.

Dates: October 5-8, 2026

Venue: The Westin Boston Seaport District, Boston, MA

4th Spatial Biology Congress co-located with 3rd Single Cell Congress: Asia 2026.

13th October 2026 - 14th October 2026

Global Engage is proud to announce the 4th Spatial Biology Congress Asia, returning on 13th and 14th October 2026 as part of a dual-track meeting in Singapore. This congress brings together leaders in spatial biology, imaging, bioinformatics and multi-omics technologies to explore the latest methods and applications transforming biological insights and translational medicine.

Over two days, delegates will benefit from expert-led presentations, panel discussions, and interactive sessions focused on spatial biology innovations, from high-plex imaging and dataset to cutting-edge analysis pipelines as well as insights to advance biomarker discovery, disease research, and clinical applications.

As part of the dual-track format, delegates can also engage with the 3rd Single Cell Congress: Asia, fostering cross-disciplinary learning and collaboration across spatial and single-cell technologies.

10% off* – Promo code: SK10_sb26

* Limited seats offer, first-come-first-serve basis, and not applicable to vendor or service/technology provider/supplier category

FormuTech Summit 2026

14th October 2026 - 15th October 2026

The FormuTech Summit brings together over 80+ senior industry experts, uniting leaders in the pharmaceutical and biotechnology sectors, as well as academia, to redefine mRNA process development, LNP formulations, and manufacturing.

Key topics include empowering mRNA advancements to ensure efficiency and therapeutic relevance, mastering LNP characterization for enhanced efficacy and safety, and overcoming global manufacturing challenges to build a resilient production landscape.

World Patient Safety Congress Americas 2026

13th October 2026 - 15th October 2026

The World Patient Safety Congress Americas (formerly known as World Drug Safety Congress Americas) is the premier global marketplace for C-suite executives, R&D specialists, and data leaders to define the future of pharmacovigilance and patient safety.

Taking place from October 13-15, 2026, at the Thomas M.Menino Convention & Exhibition Center, Boston, this event explores the intersection of drug safety strategy and technological disruption.

This premier event brings together over 1,800 leaders from pharma, biotech, and regulatory bodies to explore the future of pharmacovigilance.

The congress features over 250 speakers and 10 content tracks focusing on the role of AI, automation, and Real-World Evidence (RWE) in safety monitoring and risk management.

By bringing together international regulatory bodies, industry professionals, and patient representatives, the event aims to foster a collaborative culture of innovation that improves safety outcomes across pharmaceutical drugs, medical devices, and consumer products.

Festival of Biologics Basel 2026

13th October 2026 - 15th October 2026

The Festival of Biologics Basel is Europe’s largest biologics event, covering the start-to-finish of the industry in antibody therapies, cell and gene therapies, immunotherapies and biosimilars.

Designed for industry experts in pharma and biotech, start-ups, academics, regulators and investors, the Festival of Biologics is the meeting place for the large molecule therapy ecosystem, bringing together 3000+ attendees.

17th World ADC San Diego 2026

12th October 2026 - 15th October 2026

Connecting every corner of the ADC ecosystem, the 17th World ADC San Diego is the definitive meeting place for the global bioconjugate community.

Bringing together 1,300+ senior leaders from pharma, biotech, start-ups, academia and service providers, the event delivers an unparalleled mix of data, insights and networking.

Across seven dedicated tracks spanning discovery through to manufacturing, attendees gain practical strategies to de-risk development and accelerate ADCs into earlier lines of treatment.

Featuring cutting-edge case studies, emerging trends and high-value connections, this is the must-attend event for anyone looking to stay at the forefront of ADC innovation.

World Vaccine Congress Europe 2026

19th October 2026 - 21st October 2026

The World Vaccine Congress Europe will bring together more than 2,000 attendees, 280 speakers and over 150 exhibitors and start-ups for a comprehensive exploration of the vaccine ecosystem.

The event features presentations from leading global organizations including WHO, PATH, GSK, Moderna and CEPI, alongside panel debates addressing key scientific and policy challenges.

Attendees can benefit from extensive networking through dedicated breaks and receptions, connect with solution providers in a broad exhibition area, and engage in a dynamic start-up zone designed to link innovators with investors seeking promising early-stage vaccine technologies and fostering collaboration across the global vaccine community for progress.

Discount code: BPA20

2nd Precision Medicine Congress: Asia 2026

21st October 2026 - 22nd October 2026

Be part of Precision Medicine Asia 2026, a two-day conference scheduled for October 21-22, 2026, in Taiwan. This exceptional event will gather top experts, innovators, and industry leaders to explore the transformative possibilities of precision medicine and drug discovery in Asia.

Uncover the extraordinary potential of precision medicine at this year’s annual conference, where tailored treatments, based on genetics, environment, and lifestyle factors, take the spotlight.

This dynamic programme is featuring keynote presentations, panel discussions and poster sessions, all designed to showcase the latest innovations and practical applications in precision medicine area.

10% off* – Promo code: SK10_pm26

* Limited seats offer, first-come-first-serve basis, and not applicable to vendor or service/technology provider/supplier category

World Orphan Drug Congress Europe 2026

26th October 2026 - 28th October 2026

The is the world’s leading conferences dedicated to orphan drugs and rare diseases. Taking place from 26–28 October 2026 at the RAI Convention Centre in Amsterdam, the event will bring together more than 1,800 industry leaders, 250+ expert speakers, and over 100 exhibitors from across the global healthcare and biotech sectors.

The congress focuses on key areas such as cell and gene therapy, genetic testing, regulatory strategy, market access, patient advocacy, and real-world evidence.

It provides a major platform for networking, collaboration, and innovation, uniting pharmaceutical companies, researchers, regulators, investors, and patient organisations to advance treatments for rare diseases worldwide.

TIDES Europe 2026

03rd November 2026 - 05th November 2026

Join TIDES Europe 2026, Europe’s biggest event for oligonucleotides, peptides, mRNA, and drug delivery, from November 3-5 in Amsterdam. Meet with 900+ industry experts, gain insights from 100+ expert speakers, explore 90+ exhibitors, and attend immersive workshops.

Discover cutting-edge strategies in discovery, development, and manufacturing to accelerate therapeutics to market. Save 10% at checkout using “BioPharmaAsia10”.

Advanced Therapies USA 2026

04th November 2026 - 05th November 2026

The Advanced Therapies Congress is America’s most exciting cell and gene therapy conference and exhibition.

The conference brings together a community of 1,200 global executives at the Hynes Convention Center, Boston, to be inspired by 200 speakers and 50 start-ups over 2 incredible days.

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Global RESCON Summit 2026

10th November 2026 - 11th November 2026

The Global RESCON Summit is a prestigious and highly anticipated event, building on the success of previous editions in New York, Porto, Barcelona, and San Francisco.

Dedicated to Inhalation & Respiratory Drug Delivery | Connected Devices, the summit brings together world-leading experts from the pharmaceutical and biotechnology sectors, device manufacturers, material innovators, and academia.

13th Digital Pathology and AI Congress: Europe 2026

09th December 2026 - 10th December 2026

The 13th Digital Pathology and AI Congress: Europe 2026

The advances and applications of digital pathology; artificial intelligence and machine learning for primary diagnosis and clinical research

Date: 9th Dec 2026 to 10 Dec 2026

World EPA Congress Europe 2027

02nd March 2027 - 03rd March 2027

The World Evidence, Pricing and Access (World EPA) Congress Europe 2027 will take place from March 2–3, 2027, at the RAI Congress Centre in Amsterdam.

As Europe’s largest annual gathering for market access, pricing, and health economics, the congress will feature over 1,600 delegates, 250 expert speakers, and 120 exhibitors.

Spanning 10 focused content tracks, the event addresses critical topics including healthcare reimbursement, rare diseases, HTA/payer dynamics, digital transformation, and real-world evidence.

Global pharmaceutical leaders and policymakers will convene to share cutting-edge strategies, optimize launch pathways, and explore innovative funding models to ensure sustainable patient access to medical innovation.

World Vaccine Congress Washington 2027

08th March 2027 - 11th March 2027

The World Vaccine Congress Washington 2027 returns March 8 – 11 at the Walter E. Washington Convention Center. As the most established global vaccine event, it covers the entire value chain from basic research to commercial manufacture.

The congress will gather 3,000 senior industry experts, 400 leading speakers, and 200 innovative exhibitors to drive progress in global health.

Key tracks include pandemic preparedness, clinical trials, bioprocessing, cancer immunotherapy, and equitable vaccine access.

Attendees will experience top presentations, strategic panel debates, and extensive networking opportunities. Join science, government, and manufacturing leaders to help shape the future of global disease eradication worldwide.

Gain an exclusive extra 20% off with code BPA20

World EPA Congress USA 2027

14th September 2027 - 15th September 2027

The World Evidence, Pricing and Access Congress USA officially launches September 14–15, 2027, in Boston, establishing America’s leading forum for pharma, biotechs, payers, and HTA bodies.

This inaugural event tackles the critical friction points in healthcare delivery: balancing innovative therapy costs with sustainable patient access. Attendees will dive into real-world evidence (RWE) integration, navigating complex US pricing frameworks, and optimizing global market entry strategies.

Featuring interactive panels and presentation tracks, extensive solution-provider exhibitions, and limitless networking opportunities across two full days, the congress bridges the gap between clinical data and commercial viability – shaping the future of equitable, evidence-based healthcare access.